Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Next Generation RNA Sequencing of Glioblastoma Cancer Associated Fibrobasts

ABSTRACT: Next Generation RNA Sequencing of Glioblastoma Cancer Associated Fibrobasts

PROVIDER: PRJNA549185 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9309444.fastq.gz	Fastqsanger.gz
	SRR9309445.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Ribotag-based Next Generation Sequencing of tumor-associated astrocytes

Project description:Ribotag-based Next Generation Sequencing of tumor-associated astrocytes

| PRJNA796542 | ENA

Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer

Project description:The purpose of this study is to determine the proportion of patients diagnosed with Lynch syndrome in colorectal cancer patients with the loss of staining by immunohistochemistry (IHC) of any of the mismatch repair (MMR) proteins. Besides, this study aims to test the specificity and the sensitivity of detecting microsatellite instability (MSI) by next-generation sequencing, and to find out the consistency between IHC and MSI in colorectal cancer patients in China. In addition, researchers want to analyze the clinical characteristics and germline mutation of Lynch syndrome in Chinese population.

| 2236244 | ecrin-mdr-crc

Next Generation Sequencing from control and CD97 knockdown of glioblastoma stem cells

Project description:Next Generation Sequencing from control and CD97 knockdown of glioblastoma stem cells

| PRJNA833863 | ENA

Next Generation Sequencing from small sizes of paired normal and glioblastoma patient tissues

Project description:Next Generation Sequencing from small sizes of paired normal and glioblastoma patient tissues

| PRJNA765593 | ENA

Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing

Project description:The method to analyze the microsatellite instability (MSI) status by next-generation sequencing (NGS) has been established to assess the deficiency of DNA mismatch repair (MMR) system. The aim of our study is to evaluate the feasibility and reliability of this NGS method by testing the circulating tumor DNA (ctDNA) in blood sample of advanced colorectal cancer patients. If the result is positive, the MSI status could be easily learned without the acquisition of tissue samples.

| 2275707 | ecrin-mdr-crc

Metagenomics Next Generation Sequencing Data

Project description:Metagenomics Next Generation Sequencing Raw sequence reads

| PRJNA749647 | ENA

Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are to compare GBM transcriptome profiling (RNA-seq) after shRNA based knockdown of PRKAB1 and to compare gene expression by optimal high-throughput data analysis

2018-06-27 | GSE82183 | GEO

RNA-Seq anlalysis of prostate cancer cell lines using Next Generation Sequencing

Project description:Beginning with precursor lesions, aberrant DNA methylation marks the entire spectrum of prostate cancer progression. We mapped the global DNA methylation patterns in selected prostate tissues and cell lines using Methylplex-Next Generation Sequencing (M-NGS). Hidden Markov Model based next generation sequence analysis identified ~68,000 methylated regions per sample. While global CpG Island (CGI) methylation was not differential between benign adjacent and cancer samples, overall promoter CGI methylation increased from ~12.6% in benign samples to 19.3% and 21.8% in localized and metastatic cancer tissues, respectively. We found distinct patterns of promoter methylation around transcription start sites, where methylation occurred not only on the CGIs, but also on flanking regions and CGI sparse promoters. Among the 6,691 methylated promoters in prostate tissues, 2481 differentially methylated regions (DMRs) are cancer specific, including numerous novel DMRs. A novel cancer specific DMR in WFDC2 promoter showed heavy methylation in cancer (17/22 tissues, 6/6 cell lines), but not in the benign tissues (0/10) and normal PrEC cells. Integration of LNCaP DNA methylation and H3K4me3 data suggested an epigenetic mechanism for alternate transcription start site utilization and these modifications segregated into distinct regions when present on the same promoter. Finally, we observed differences in repeat element methylation, particularly LINE-1, between ERG gene fusion positive and negative cancers. This comprehensive methylome map will further our understanding of epigenetic regulation in prostate cancer progression. Next generation Sequencing for Gene expression using the RNA-Seq methodology from LNCaP and PrEC cell lines

2011-05-09 | E-GEOD-29155 | biostudies-arrayexpress

Next Generation Sequencing of CRC tissue

Project description:Next Generation Sequencing of CRC tissue

| PRJNA575027 | ENA

Next-Generation Sequencing Analysis of ChIP

Project description:Next-Generation Sequencing Analysis of ChIP

| PRJNA604796 | ENA